Silo Pharma shares surge 38.19% premarket after announcing $1M share buyback program.

Silo Pharma (NASDAQ: SILO) surged 38.19% in premarket trading following the announcement of a $1 million share repurchase program authorized by its board. The program, which permits open-market or privately negotiated purchases, signals management’s confidence in the stock’s undervaluation and aims to enhance shareholder value. The move aligns with positive investor sentiment, as share buybacks typically indicate a company’s commitment to returning capital and boosting equity value. With 13.3 million shares outstanding, the buyback represents a strategic step to reduce supply and potentially elevate earnings per share, though execution remains subject to market conditions and regulatory constraints. The premarket rally reflects immediate optimism around the initiative, underscoring its significance as a catalyst for near-term momentum.